3dda
From Proteopedia
Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
- | [[Image:3dda. | + | [[Image:3dda.png|left|200px]] |
<!-- | <!-- | ||
Line 12: | Line 12: | ||
===Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide=== | ===Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide=== | ||
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_18818739}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 18818739 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_18818739}} | ||
==About this Structure== | ==About this Structure== | ||
- | 3DDA is a | + | 3DDA is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Clostridium_botulinum Clostridium botulinum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3DDA OCA]. |
+ | |||
+ | ==Reference== | ||
+ | Substrate binding mode and its implication on drug design for botulinum neurotoxin A., Kumaran D, Rawat R, Ahmed SA, Swaminathan S, PLoS Pathog. 2008 Sep 26;4(9):e1000165. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18818739 18818739] | ||
[[Category: Bontoxilysin]] | [[Category: Bontoxilysin]] | ||
[[Category: Clostridium botulinum]] | [[Category: Clostridium botulinum]] | ||
- | [[Category: Protein complex]] | ||
[[Category: Kumaran, D.]] | [[Category: Kumaran, D.]] | ||
[[Category: Swaminathan, S.]] | [[Category: Swaminathan, S.]] | ||
Line 44: | Line 52: | ||
[[Category: Zinc]] | [[Category: Zinc]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 24 11:04:20 2008'' |
Revision as of 09:04, 24 December 2008
Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide
Template:ABSTRACT PUBMED 18818739
About this Structure
3DDA is a 2 chains structure of sequences from Clostridium botulinum. Full crystallographic information is available from OCA.
Reference
Substrate binding mode and its implication on drug design for botulinum neurotoxin A., Kumaran D, Rawat R, Ahmed SA, Swaminathan S, PLoS Pathog. 2008 Sep 26;4(9):e1000165. PMID:18818739
Page seeded by OCA on Wed Dec 24 11:04:20 2008
Categories: Bontoxilysin | Clostridium botulinum | Kumaran, D. | Swaminathan, S. | Alternative splicing | Bio-warfare agent | Botox | Botulinum neurotoxin type some | Catalytic domain | Cell junction | Coiled coil | Endopeptidase | Enzyme-substrate complex | Hydrolase | Lipoprotein | Metal-binding | Metalloprotease | Palmitate | Pharmaceutical | Phosphoprotein | Protease | Secreted | Synapse | Synaptosome | Syntaxin | Transmembrane | Zinc